BioSpace News Archive

T2 Biosystems, Inc. a leader in the rapid detection of sepsis-causing pathogens, announced that it issued inducement awards to four new employees.

According to a new study published by Persistence Market Research (PMR), the global human platelet lysate market is estimated to be valued at US$ 45.8 Mn in 2018 and is expected to expand at a CAGR of 3.6% over 2018–2026, to reach US$ 61.0 Mn by 2026 end.

Persistence Market Research delivers key insights on the global scoliosis management market in its upcoming outlook titled “Scoliosis Management Market: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2028”. In terms of value, the global scoliosis management market is projected to register a CAGR of 3.6% during the forecast period due to various factors, regarding which the report offers vital insights in detail.

Patients suffering from critical lifestyle diseases are benefited the most and manufacturers are integrating technology to build cutting-edge products that can meet the increasing demand from the healthcare industry. Wearable injectors with monitoring devices to help doctors track patient records are being developed to help reduce the number of hospital visits.

Rising prevalence of obesity, growing geriatric population with higher risk of heart diseases, and rapid technological advancements to detect arrhythmia are critical factors for the growth of the transseptal access systems market. Introduction of innovative technologies such as left atrial appendage occlusion therapy is benefitting patients who are at high risk of strokes due to non-valvular atrial fibrillation (AF).

AquiSense Technologies, the world leader in ultraviolet (UV) LED disinfection technology, is happy to announce it has launched the PearlSurface 24G9™, one of the first UV-C LED surface disinfection products designed for health care applications such as reuse of N95 face mask and other PPE.

Fund will help team members with rent, groceries, dependent care and other needs

Protagonist Therapeutics, Inc. reported that on April 15, 2020, it issued an inducement award to Tracy Woody, the Company’s recently hired Executive Vice President of Corporate Strategy, in accordance with the terms of Ms. Woody’s employment offer letter.

Athersys, Inc. announced the pricing of its previously announced underwritten public offering of its common stock, par value $0.001 per share, at a price to the public of $2.25 per share, for a total of 22,250,000 shares.

Quansys Biosciences in Logan, Utah , released their SARS-CoV-2 Human IgG(4-plex) enzyme-linked immunosorbent assay (ELISA) for the qualitative detection of SARS-CoV-2 reactive IgG class antibodies in human serum and plasma. SARS-CoV-2 is the novel coronavirus responsible for COVID-19.